Show
Sort by
-
Global access and patient safety in the transition to environmentally friendly respiratory inhalers : the Global Initiative for Asthma perspective
-
Response to the correspondence : 'Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma'
-
- Journal Article
- A1
- open access
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma
-
Response to comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)
-
GINA 2019 : a fundamental change in asthma management
-
Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices
-
Allergic Rhinitis and its Impact on Asthma (ARIA) phase 4 (2018) : change management in allergic rhinitis and asthma multimorbidity using mobile technology
-
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
-
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
-
Integrating real-life studies in the global therapeutic research framework